Verona Pharma PLC (VRNA)

42.06 +0.84 (+2.04%) USD  |  NASDAQ  |  Dec 20, 16:00
42.08 +0.02 (+0.05%) After-Hours: 20:00
More

Verona Pharma Price to Book Value: 26.38 for Dec. 20, 2024

Price to Book Value Chart

View Price to Book Value for VRNA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price to Book Ratio Definition

View Price to Book Ratio Definition
Start Trial

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
TC BioPharm (Holdings) PLC 2.163
Adaptimmune Therapeutics PLC 1.935
Biodexa Pharmaceuticals PLC 0.2052
DBV Technologies SA 1.211
Autolus Therapeutics PLC 1.278

Price to Book Value Related Metrics

PEG Ratio -0.0818
Price 42.06
Earnings Yield -4.76%
Market Cap 3.442B
PEGY Ratio -0.0818